Notification letter and reply form
Filed with HKEX · Stock code 690 · · 2 pages · English and Chinese
Summary by 6ix AI
The letter informs registered shareholders that both English and Chinese versions of the interim report are available on the company's website and the Hong Kong Stock Exchange's website. Shareholders are encouraged to provide their email addresses to receive future corporate communications electronically. If shareholders prefer printed copies, they can request them using the enclosed reply form.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Uni Bio Science Group, Ltd. on 6ix
Earlier from Uni Bio Science
- Notification letter and request form
- Interim Report 2026
- Uni Bio Science Secures Approval for Recombinant Collagen Class II Medical Device and Launches 肌顏態®: Pioneering Entry into the High Growth Medical Aesthetics Market
- Uni Bio Science Announces 2022 Annual Results，Record High Turnover of HK$440.3 Million and HK$38.5 Million Profit Achieved Expanding Portfolio with New Drug Innovations and Strategic R&D Partnerships
- Interim Report 2022
Later from Uni Bio Science
- Monthly return of equity issuer on movements in securities for the month ended 30 September 2026
- Monthly return of equity issuer on movements in securities for the month ended 31 October 2026
Follow Uni Bio Science into a list and get an email when it puts out news.
Follow Uni Bio Science